Taiwan FDA registration a34178dc9141c2e5bcb185310e7acb9a
"Bidi" tuberculosis flora testing test
TW: "必帝" 結核菌群檢定試藥
Taiwan·Risk Class 1·NIPPON BD COMPANY, LTD.·Registered Jun 14, 2006 – Jun 14, 2011CancelledRegistration details
- Analysis ID
- a34178dc9141c2e5bcb185310e7acb9a
- Customs Code
- DHA04400470502
Company information
- Manufacturer
- NIPPON BD COMPANY, LTD.
- Manufacturer Country
- Japan
- Authorized Representative
- Taiwan Branch of American Business Bidi Co., Ltd
Product details
- Intended Use
- Immunochromatography was used to detect Mycobacterium tuberculosis antigen MPB64 in the culture medium. The results of this test should be determined in conjunction with the report of other test methods and the clinical symptoms of the subject.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.2660 微生物鑑別及測定器材
- Import Information
- import
Dates and status
- Registration Date
- Jun 14, 2006
- Expiry Date
- Jun 14, 2011
- Cancellation Date
- Oct 26, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "Bidi" tuberculosis flora testing test in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number a34178dc9141c2e5bcb185310e7acb9a and manufactured by NIPPON BD COMPANY, LTD.. The authorized representative in Taiwan is Taiwan Branch of American Business Bidi Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices